These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2751951)

  • 1. Reporting the assessment of screening and diagnostic tests.
    Wald N; Cuckle H
    Br J Obstet Gynaecol; 1989 Apr; 96(4):389-96. PubMed ID: 2751951
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for disease: Definitions and criteria.
    Whitby LG
    Lancet; 1974 Oct; 2(7884):819-22. PubMed ID: 4138246
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating validity of screening tests.
    Larson E
    Nurs Res; 1986; 35(3):186-8. PubMed ID: 3635057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening tests in early diagnosis.
    Ferrer HP
    Ann Soc Belges Med Trop Parasitol Mycol; 1970; 50(4):437-45. PubMed ID: 5518686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening. What documentation should be required?].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for false positive and for false negative test results in screening with fecal occult blood testing.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam M; van Ballegooijen M; Kraaijenhagen RA; Fockens P; Kuipers EJ; Dekker E; Bossuyt PM
    Int J Cancer; 2013 Nov; 133(10):2408-14. PubMed ID: 23649826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arguments against mandatory screening for HIV in low-prevalence areas.
    Lovejoy NC
    J Assoc Nurses AIDS Care; 1991; 2(2):7-14. PubMed ID: 1868230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age.
    Johnson SL; Tabaei BP; Herman WH
    Diabetes Care; 2005 Feb; 28(2):307-11. PubMed ID: 15677784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On improving the diagnostic value of quantitative medical laboratory tests in health screening.
    Weldon KL; MacKay JS
    J Chronic Dis; 1972 Dec; 25(12):697-709. PubMed ID: 4648514
    [No Abstract]   [Full Text] [Related]  

  • 11. Faecal occult blood testing for colorectal cancer: luxury or necessity?
    Agrez M; Evans D; Duggan J
    Aust N Z J Surg; 1990 Jun; 60(6):451-4. PubMed ID: 2346441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening for carcinoma of the cervix today].
    Calzolari E; Ciampaglia G; Coppola S
    Minerva Ginecol; 1996 Nov; 48(11):453-61. PubMed ID: 9005371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of expanded HIV screening.
    Lander D
    Ann Intern Med; 2007 Jul; 147(2):145-6; author reply 146-7. PubMed ID: 17638721
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosing tests: using and misusing diagnostic and screening tests.
    Streiner DL
    J Pers Assess; 2003 Dec; 81(3):209-19. PubMed ID: 14638445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How serious are the adverse effects of screening?
    Feldman W
    J Gen Intern Med; 1990; 5(5 Suppl):S50-3. PubMed ID: 2231065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of likelihood ratio computation to standardize the predictive power of noninvasive cardiovascular tests.
    Montori VM; Ebbert JO
    Mayo Clin Proc; 2000 Apr; 75(4):423-4. PubMed ID: 10761502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening: an appealing but problematic concept].
    Lagerlund M; Zackrisson S
    Lakartidningen; 2013 Mar 20-26; 110(12):628-30. PubMed ID: 23614209
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO recommends against inaccurate tuberculosis tests.
    Morris K
    Lancet; 2011 Jan; 377(9760):113-4. PubMed ID: 21226229
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammographic screening for breast cancer: prospects for New Zealand.
    Skegg D; Paul C; Benson-Cooper D; Chetwynd J; Clarke A; Fitzgerald N; Gray A; St George I; Simpson A
    N Z Med J; 1988 Aug; 101(852):531-3. PubMed ID: 3045716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are clinical laboratory tests performed? When are they valid?
    Krieg AF; Gambino R; Galen RS
    JAMA; 1975 Jul; 233(1):76-8. PubMed ID: 1173430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.